LGOPX
Price
$25.78
Change
+$0.46 (+1.82%)
Updated
Jun 24 closing price
Net Assets
606.2M
PMBPX
Price
$45.49
Change
+$0.40 (+0.89%)
Updated
Jun 24 closing price
Net Assets
31B
Interact to see
Advertisement

LGOPX vs PMBPX

Header iconLGOPX vs PMBPX Comparison
Open Charts LGOPX vs PMBPXBanner chart's image
Lord Abbett Growth Opportunities P
Price$25.78
Change+$0.46 (+1.82%)
VolumeN/A
Net Assets606.2M
Principal MidCap R5
Price$45.49
Change+$0.40 (+0.89%)
VolumeN/A
Net Assets31B
LGOPX vs PMBPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LGOPX vs. PMBPX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGOPX is a Buy and PMBPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 31B vs. LGOPX (606M). PMBPX pays higher dividends than LGOPX: PMBPX (0.01) vs LGOPX (0.00). LGOPX was incepted earlier than PMBPX: LGOPX (25 years) vs PMBPX (25 years). LGOPX (1.35) is less costly to investors than PMBPX (0.83). LGOPX is a more actively managed with annual turnover of: 117.00 vs. PMBPX (10.50). LGOPX (0) and PMBPX (0) have matching initial minimum investment requirements. LGOPX annual gain was more profitable for investors over the last year : 24.12 vs. PMBPX (10.82). PMBPX return over 5 years is better than : 57.01 vs. LGOPX (3.52).
LGOPXPMBPXLGOPX / PMBPX
Total Expense Ratio1.160.83140%
Annual Report Gross Expense Ratio1.350.83163%
Fund Existence25 years25 years-
Gain YTD5.5883.751149%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets606M31B2%
Annual Yield % from dividends0.000.01-
Returns for 1 year24.1210.82223%
Returns for 3 years42.8945.7094%
Returns for 5 years3.5257.016%
Returns for 10 years13.2494.7714%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCAX9.510.33
+3.59%
Bicara Therapeutics Inc.
SINT3.110.04
+1.30%
SiNtx Technologies Inc.
KNSA29.060.34
+1.18%
Kiniksa Pharmaceuticals International plc
ETON13.590.08
+0.59%
Eton Pharmaceuticals
GWRE237.45-0.95
-0.40%
Guidewire Software